Table 3 Treatment differences on baseline covariates by intravenously administered alteplase status at interim analysis (N = 316)
Baseline covariates | IV alteplase (n = 237) | Without IV alteplase (n = 78) | ||||
|---|---|---|---|---|---|---|
Treatment (n = 120) | Control (n = 117) | p value | Treatment (n = 45) | Control (n = 33) | p value | |
Age (mean, SD) | 69.16 (12.32) | 68.43 (14.89) | 0.68 | 69.76 (16.31) | 69.45 (13.19) | 0.93 |
NIHSS score (mean, SD) | 16.38 (5.35) | 16.69 (5.75) | 0.66 | 16.93 (5.60) | 15.73 (5.43) | 0.34 |
Sex (% female) | 50.00% | 51.28% | 0.844 | 57.78% | 57.58% | 0.99 |
ASPECTS score (% (8–10)) | 66.67% | 70.09% | 0.572 | 60.00% | 72.73% | 0.24 |
Baseline occlusion location (% MCA M1) | 73.33% | 72.65% | 0.906 | 73.33% | 75.76% | 0.81 |